Lyrica Orally Disintegrating Tablet 50mg (Pregabalin)

Adult dosage

This medication is to be taken orally, divided into two doses per day, regardless of meals. Place on the tongue to disintegrate, then swallow without water. 1. Neuropathic Pain - Peripheral Neuropathic Pain: Starting dose may be 150 mg per day. Depending on individual response and tolerance, it may be increased to 300 mg per day within 3 to 7 days. If necessary, it can be further increased to a maximum of 600 mg per day at 7-day intervals. - Central Neuropathic Pain

Children's dosage

Due to insufficient safety and efficacy data for children under 12 years of age and adolescents aged 12-17, usage is not recommended.

This medication may increase the risk of suicidal thoughts or behavior, so any changes in mood or unusual behavior should be reported to a healthcare professional immediately during the course of treatment. Patients with a history of allergy or hypersensitivity to any component of this medication should not use it. Diabetic patients may require adjustment of their blood sugar control medications due to weight gain. If serious allergic reactions such as angioedema occur, the medication should be stopped immediately and medical advice sought. Elderly patients should be cautious of the risk of falls due to dizziness or drowsiness, especially during the initial stages of use. Patients may experience temporary blurred vision or changes in vision; if symptoms persist, consult a healthcare professional. Sudden discontinuation of this medication can lead to withdrawal symptoms including insomnia, headache, anxiety, and others, so it should be tapered gradually in consultation with a healthcare professional. Patients with a history of drug abuse are at risk of misuse or dependency on this medication and should exercise caution. Patients with reduced kidney function may require dose adjustments of this medication. Patients with heart disease should be cautious of the risk of congestive heart failure while taking this medication. Taking this medication with opioid analgesics can enhance central nervous system depressant effects, increasing the risk of respiratory depression; caution is advised. This medication can cause dizziness and drowsiness, so caution is necessary when driving or operating dangerous machinery. In early pregnancy, there is a risk of congenital anomalies to the fetus; therefore, pregnant women are advised not to take this medication, and women of childbearing potential should use effective contraception. While breastfeeding, this medication may pass into breast milk and affect an infant, so consideration should be given to stopping breastfeeding or the medication. In the case of overdose, symptoms such as confusion, drowsiness, depression, and seizures may occur, and immediate medical treatment should be sought. Keep out of reach of children, and do not transfer to another container to maintain the quality of the medication. During treatment with this medication, serious adverse reactions such as skin rash, fever, and breathing difficulties may occur; if these symptoms arise, the medication should be stopped immediately and medical advice sought.

Serious side effects

Hives, severe swelling (edema), angioedema, facial swelling, swelling around the face, mouth, and upper airway, chest tightness, difficulty breathing, cold sweat, paleness, severe rash with high fever, blisters, skin peeling, pain in oral/ocular mucosa, Stevens-Johnson syndrome, toxic epidermal necrolysis, mucous membrane syndrome, anaphylaxis-like symptoms, shortness of breath or difficulty breathing, asthma attacks, respiratory issues accompanied by cough and fever, lung problems.

Mild side effects

• Dizziness
• drowsiness
• confusion
• loss of orientation
• irritability
• depression
• feelings of euphoria
• decreased libido
• insomnia
• depersonalization

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius. Proper storage will help to preserve the effectiveness of the medication for a longer period.

Appearance

Yellow round orally disintegrating tablet

Package unit

30 tablets/PTP [10 tablets/PTP x 3], 100 tablets/PTP [10 tablets/PTP x 10]